[DowJonesToday]Dow Jones Flat as Industrial Strength Offsets Tech Weakness
The Dow Jones Industrial Average (^DJI) was up 2.48 (+0.0050%) points today, trading at 49,528.65, while Dow Futures (YM=F) was […]
Tech Retreats as Energy and Financials Pivot: Nasdaq Slides 1% Ahead of Nvidia Earnings
Afternoon trading on Monday, May 18th, 2026, reveals a stark divide on Wall Street as investors rotate out of high-growth
U.S. Issues Temporary Russian Oil Waiver Amid Global Supply Crunch; Citi and BlackRock Strike €15B Deal
Key Takeaways U.S. Treasury issues a 30-day temporary license for Russian oil to stabilize the physical crude market and support
[DowJonesToday]Dow Jones Flat as Inflation Concerns Spark Sector Rotation
The Dow Jones Industrial Average (^DJI) was down 33.44 (-0.07%) points today, trading at 49,492.73 as investors reacted to a
Tech Sector Under Pressure as Energy and Defensive Stocks Lead Midday Trading
Midday trading on Monday, May 18th, 2026, reveals a starkly divided U.S. stock market. While the broader averages are struggling
Global Markets Rise Amid Escalating Iran War Risks and EU Stagflation Warnings
Key Takeaways US-Iran tensions have reached a critical impasse as officials warn that Iran's latest proposal is "insufficient," significantly increasing
[DowJonesToday]Dow Jones Today: Industrial Strength Fails to Offset Enterprise Tech Weakness
The Dow Jones Index (^DJI) was down 23.05 (-0.0465%) points today, as the blue-chip average struggled for momentum on Monday,
Oil Prices Turn Positive Amid Iran Tensions; US Housing Data Surprises to the Upside
Key Takeaways Oil futures turned positive in volatile trading as escalating tensions between the US and Iran and reports of
Mixed Start for Wall Street as Tech Lags and Retail Giants Loom
The U.S. stock market opened the week of Monday, May 18th, 2026, with a cautious and fragmented performance. Investors are
SCOTUS Upholds Medicare Price Curbs as Markets Edge Higher; Iran Peace Leaks Surface
Key Takeaways The U.S. Supreme Court (SCOTUS) rejected a major pharmaceutical industry challenge to the Biden-era Medicare drug price curbs,